Harel Insurance Investments & Financial Services’s 10x Genomics TXG Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-582	Closed	-$372K	–	802
2021 Q2	$372K	Sell	582 -418	-42%	-$75.6K	0.01%	511
2021 Q1	$605K	Buy	+1,000	New	+$173K	0.01%	478
2020 Q4	–	Sell	-500	Closed	-$62K	–	786
2020 Q3	$62K	Buy	+500	New	+$52.5K	﹤0.01%	437

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harel Insurance Investments & Financial Services's TXG Position: Q3 2021 in Review

Harel Insurance Investments & Financial Services sold out of 10x Genomics (TXG) in Q3 2021, closing a stake of 582 shares — an estimated $372K sold.

Harel Insurance Investments & Financial Services first reported a position in TXG in Q3 2020 and held it in 3 quarters. The position peaked at $605K in Q1 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q3 2021.

Harel Insurance Investments & Financial Services reported no remaining 10x Genomics position as of Q3 2021 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 582 10x Genomics shares in Q3 2021, an estimated $372K.
Harel Insurance Investments & Financial Services first reported a position in 10x Genomics in Q3 2020 and held it in 3 quarters.
Harel Insurance Investments & Financial Services's 10x Genomics position peaked at $605K in Q1 2021.
330 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2021, filed 25 Oct 2021.